Evolent Health, Inc. – NYSE:EVH
Founder-led company
Evolent Health stock price today
$9.01
-2.12
-19.05%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in 2 minutes
Evolent Health stock price monthly change
-43.47%
month
Evolent Health stock price quarterly change
-43.47%
quarter
Evolent Health stock price yearly change
-66.46%
year
Evolent Health key metrics
Market Cap | 1.30B |
Enterprise value | 3.48B |
P/E | -160.25 |
EV/Sales | 2.57 |
EV/EBITDA | 172.36 |
Price/Sales | 2.36 |
Price/Book | 3.72 |
PEG ratio | -2.93 |
EPS | -0.98 |
Revenue | 2.17B |
EBITDA | 119.14M |
Income | -110.33M |
Revenue Q/Q | 49.55% |
Revenue Y/Y | 46.75% |
Profit margin | -1.42% |
Oper. margin | -1.47% |
Gross margin | 23.42% |
EBIT margin | -1.47% |
EBITDA margin | 5.48% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEvolent Health stock price history
Evolent Health stock forecast
Evolent Health financial statements
Average Price Target
$33
Potential upside: 266.25%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 469.13M | -34.32M | -7.32% |
|---|---|---|---|
| Sep 2023 | 511.01M | -25.32M | -4.96% |
| Dec 2023 | 556.05M | -33.41M | -6.01% |
| Mar 2024 | 639.65M | -17.28M | -2.7% |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | |
|---|---|
| 2020 | 1.47% |
| 2021 | 0.05% |
| 2022 | 0.57% |
| 2023 | 0.51% |
| Jun 2023 | 2646831000 | 1.55B | 58.7% |
|---|---|---|---|
| Sep 2023 | 2669615000 | 1.57B | 58.94% |
| Dec 2023 | 2680308000 | 1.61B | 60.16% |
| Mar 2024 | 2643673000 | 1.59B | 60.36% |
| Jun 2023 | 654K | -8.35M | 23.33M |
|---|---|---|---|
| Sep 2023 | 60.52M | -6.14M | -37.36M |
| Dec 2023 | 89.38M | -6.05M | -84.35M |
| Mar 2024 | 4.90M | -9.73M | 14.88M |
Evolent Health alternative data
| Aug 2023 | 5,100 |
|---|---|
| Sep 2023 | 5,100 |
| Oct 2023 | 5,100 |
| Nov 2023 | 5,100 |
| Dec 2023 | 5,100 |
| Jan 2024 | 5,100 |
| Feb 2024 | 5,100 |
| Mar 2024 | 4,700 |
| Apr 2024 | 4,700 |
| May 2024 | 4,700 |
| Jun 2024 | 4,700 |
| Jul 2024 | 4,700 |
Evolent Health other data
99.60%
+0.87%
of EVH is owned by hedge funds
207
+5
85.71M
+1.01M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2023 | 0 | 110000 |
| Feb 2023 | 0 | 110000 |
| Mar 2023 | 0 | 476590 |
| Apr 2023 | 0 | 110000 |
| May 2023 | 0 | 110000 |
| Jun 2023 | 0 | 241969 |
| Aug 2023 | 0 | 7900 |
| Nov 2023 | 0 | 7000 |
| Dec 2023 | 0 | 141000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | BLACKLEY SETH director, officer.. | Class A Common Stock | 27,484 | $25.74 | $707,438 | ||
Sale | BLACKLEY SETH director, officer.. | Class A Common Stock | 92,616 | $26.61 | $2,464,512 | ||
Sale | BLACKLEY SETH director, officer.. | Class A Common Stock | 20,900 | $27.25 | $569,525 | ||
Option | BLACKLEY SETH director, officer.. | Class A Common Stock | 280,000 | N/A | N/A | ||
Option | BLACKLEY SETH director, officer.. | Leveraged Restricted Stock Unit | 280,000 | N/A | N/A | ||
Sale | MCCARTHY DANIEL JOSEPH officer: PRESIDENT | Class A Common Stock | 4,000 | $30 | $120,000 | ||
Option | MCCARTHY DANIEL JOSEPH officer: PRESIDENT | Class A Common Stock | 3,000 | $10.65 | $31,950 | ||
Option | MCCARTHY DANIEL JOSEPH officer: PRESIDENT | Class A Common Option (right to buy) | 3,000 | $10.65 | $31,950 | ||
Sale | MCCARTHY DANIEL JOSEPH officer: PRESIDENT | Class A Common Stock | 3,000 | $30 | $90,000 | ||
Sale | RAFFERTY EMILY ANN officer: Chief Operating Officer | Class A Common Stock | 7,900 | $28.05 | $221,595 |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 22 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 4 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 2 Aug 2023 | Q2 2023 Earnings Call Transcript |
DOGE's Potential Impact - Top 10 IT And Software Companies With Exposure To The U.S. Government
A First Evaluation On Evolent Health
Evolent Health: Business Economics Still Appealing, Reiterate Buy
Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return
Allscripts Healthcare Solutions: The Picture Is Improving
Evolent Health: A Bit Complex, But Interesting
Evolent Health: Improving Financials, But There's More
Premier: Attractively Valued In An Important Market
Evolent Health: Healthy Growth, But That Is About It
-
What's the price of Evolent Health stock today?
One share of Evolent Health stock can currently be purchased for approximately $9.01.
-
When is Evolent Health's next earnings date?
Unfortunately, Evolent Health's (EVH) next earnings date is currently unknown.
-
Does Evolent Health pay dividends?
No, Evolent Health does not pay dividends.
-
How much money does Evolent Health make?
Evolent Health has a market capitalization of 1.30B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 45.26% to 1.96B US dollars.
-
What is Evolent Health's stock symbol?
Evolent Health, Inc. is traded on the NYSE under the ticker symbol "EVH".
-
What is Evolent Health's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Evolent Health?
Shares of Evolent Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Evolent Health's key executives?
Evolent Health's management team includes the following people:
- Mr. Seth Barrie Blackley Co-Founder, Chief Executive Officer & Director(age: 46, pay: $1,150,000)
- Mr. Frank John Williams Co-Founder & Non-Executive Chairman(age: 58, pay: $1,110,000)
- Mr. Steve Tutewohl Chief Operating Officer(age: 52, pay: $1,090,000)
- Mr. John Paul Johnson Chief Financial Officer(age: 41, pay: $761,400)
- Mr. Jonathan David Weinberg Chief Legal Officer, Gen. Counsel & Sec.(age: 57, pay: $513,070)
- Mr. Aammaad Shams Principal Accounting Officer & Corporation Controller(age: 41, pay: $316,230)
-
Is Evolent Health founder-led company?
Yes, Evolent Health is a company led by its founders Mr. Seth Barrie Blackley and Mr. Frank John Williams.
-
How many employees does Evolent Health have?
As Jul 2024, Evolent Health employs 4,700 workers.
-
When Evolent Health went public?
Evolent Health, Inc. is publicly traded company for more then 10 years since IPO on 5 Jun 2015.
-
What is Evolent Health's official website?
The official website for Evolent Health is evolenthealth.com.
-
Where are Evolent Health's headquarters?
Evolent Health is headquartered at 800 North Glebe Road, Arlington, VA.
-
How can i contact Evolent Health?
Evolent Health's mailing address is 800 North Glebe Road, Arlington, VA and company can be reached via phone at +57 1 3896000.
-
What is Evolent Health stock forecast & price target?
Based on 3 Wall Street analysts` predicted price targets for Evolent Health in the last 12 months, the avarage price target is $33. The average price target represents a 266.25% change from the last price of $9.01.
Evolent Health company profile:
Evolent Health, Inc.
evolenthealth.comExchange:
NYSE
Full time employees:
4,700
Industry:
Medical - Healthcare Information Services
Sector:
Healthcare
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
800 North Glebe Road
Arlington, VA 22203
Arlington, VA 22203
CIK: 0001628908
ISIN: US30050B1017
CUSIP: 30050B101
